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Mitochondrial diseases are a plethora of oxidative phosphoryla-
tion (OXPHOS) related disorders, which have an estimated preva-
lence of, 1:5000 in children and 1:10,000 in adults. Mitochondrial
disorders in adulthood generally are caused by mutations in the
mitochondrial DNA (mtDNA), whereas pediatric disorders are often
associated with nuclear DNA (nDNA) mutations. The inheritance of
these disorders, could be maternal or mendelian depending on the
origin, if the mutation is in the mtDNA or nDNA respectively [1,2].
Most mitochondrial functions, including aerobic ATP production,
require an inside negative potential (Δψ) across the mitochondria
inner membrane (MIM). This Δψ is sustained by the action of the
electron transport chain (ETC), which together with the ATP-
synthesizing F0F1-ATPase, constitutes the oxidative phosphorylation
(OXPHOS) system. The ETC consists of four complexes (CI–CIV) of
which CI is the largest and least well understood. Importantly,
inherited mutations in nDNA-encoded CI subunits are the most
frequent cause of OXPHOS deﬁciency in humans. In this project we
use a knockout animal model with severe nDNA CI dysfunction,
displaying behavioral and pathophysiological changes leading to
disease symptoms and a lethal phenotype [3].
We analyzed the biochemical and metabolic consequences of this
dysfunction in tissues with high energy demand at the level of
substrate oxidation, ATP production and biochemical activities of the
respiratory chain complexes. Our ﬁndings indicate, that there is tissue
speciﬁc adaptation seen in the skeletal muscle and the heart, however
we do not observe the same adaptation in the brain. This leads us to
conclude that the brain is the most affected tissue due to CI
deﬁciency. We believe that our data will help in creating rational
mitigative strategies, which will be targeting the brain to treat this
fatal phenotype.
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Respiratory complex I is present in the three domains of life and
plays a central role in energy transduction. It catalyzes the oxidation
of NADH and reduction of quinones, coupled to cation translocation
across the membrane, thereby establishing an electrochemical
potential. It is a large enzyme composed by a peripheral and a
membrane part in an L-shaped assembly. This enzyme is an example
of the modular structure observed in several energy transducing
enzymes. The complex I from prokaryotes may be viewed as a
combination of 14 modules most of which identiﬁed in other
complexes, such as type 4 membrane-bound [NiFe] hydrogenases
and some subunits of Mrp Na+/H+ antiporters.
In this work we put forward a thorough taxonomic proﬁle of
prokaryotic type 4 membrane-bound [NiFe] hydrogenases, complex I
and complex I-like enzymes which have at least four common
subunits that we dominated as the universal adaptor (NuoH, L, B
and D). In addition we investigated the different gene clustering
organization of such complexes. We showed the presence of
complexes related to hydrogenases, named before Ehr (Energy-
converting hydrogenases related complexes), but which do not
contain the binding site of the catalytic centre (NiFe). These
complexes are a missing link between complex I and type 4
membrane-bound [NiFe]-hydrogenases. Based on our observation
we discuss the evolutionary, functional and mechanistic implications
of a different perspective for the relation between complex I and
related enzymes.
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NADH:quinone oxidoreductase (complex I) is the ﬁrst enzyme of
the respiratory chain and the entry point for NADH, a high energy
electron carrier. The mammalian complex consists of 45 subunits
with a combined mass of 980 kDa, whilst its highly conserved
bacterial homologue contains approximately 14 subunits with a mass
of 550 kDa. The prokaryotic enzyme still maintains the core
bioenergetics function and therefore represents a minimal model for
the mammalian enzyme. Complex I catalyses the reduction of
quinone to quinol by transferring electrons from NADH, via a series
of non-covalently bound prosthetic groups. The process of electron
transfer is coupled to proton translocation across the membrane
which establishes a proton motive force; the mechanism, however,
remains largely unknown.
Quinone is proposed to bind at the interface between the
hydrophilic and membrane domain. The present structure of complex
I from Thermus thermophilus [1] suggests that once quinone is bound
to the membrane domain, it has to move into the hydrophilic domain
by up to 20 Å, to be within close proximity of the N2 iron–sulphur
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cluster to permit physiological electron transfer. The unusually large
movement could suggest a mechanism for coupling. To gain further
insight into the mechanism of complex I, we describe a series of
experiments on structural and functional characterisation of the
interaction between T. thermophilus complex I and quinone or
quinone-like inhibitors.
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Dietary restriction (DR) extends lifespan in many strains of mice.
It is accompanied by the reduction in reactive oxygen species (ROS)
release from complex I of the mitochondria from various tissues, and
aging is found to increase it. However, the nature of mitochondrial
alterations resulting in these observations is not fully understood.
We compared the proteome of puriﬁed liver mitochondria using 6-
plex isobaric labelling, isoelectric focusing and LC-MS/MS from young
mice in which lifespan was prolonged by either DR or genetically (long
lived strain, ICRFa) and old mice. We developed a Bayesian model that
enabled us to detect small differences in protein abundance with high
conﬁdence. DR induced a number of speciﬁc changes in liver
mitochondria including enrichment of proteins involved in fatty acid
metabolism, amino acid degradation and TCA cycle. Importantly, the
abundance of speciﬁc components of the electron transport chain and of
prohibitins 1 and 2 were similarly decreased in all young mice with
enhanced longevity, andmany of themwere enriched in oldmice. Most
interestingly, the changes within complex I were highly clustered: We
quantiﬁed 31 out of the 45 known protein subunits of complex I. None
of the subunits belonging to the membrane hydrophilic arm were
signiﬁcantly changed among the groups, but 14 out of the 17 identiﬁed
proteins forming the matrix arm of complex I, where all the catalytic
centres are located, were downregulated under DR;many of themwere
also downregulated in genetically long lived mice but became enriched
in old. Blue native electrophoresis conﬁrmed that DR decreased the
abundance of partially assembled complex I sub-complexes.
Our observations suggest the intriguing possibility that a balanced
composition of complex I and its proper assembly might regulate
mitochondrial function and thus ageing: higher abundance of
complex I catalytic subunits that are not completely assembled
would not improve electron transport but might enhance ROS
production. This could explain why short-lived and older animals
show less efﬁcient oxygen consumption together with increased ROS
production from complex I.
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The respiratory complex I couples the electron transfer from
NADH to ubiquinone with a proton translocation across the
membrane. The bacterial complex consists of 13 to 15 subunits and
harbors one FMN and seven to ten Fe/S-clusters depending on the
species. The X-ray structure of the complex revealed that the NADH
binding site is made up by a novel type of Rossman-fold providing
binding sites for FMN and NADH [1]. We solved the structure of the
NADH binding site of the Aquifex aeolicus complex with bound
substrates at 2 Å resolution [2]. We showed that Glu183 on NuoF
plays a central role in discriminating NADH and NADPH as substrates.
Glu183 was replaced by Gln, Asp, Asn, His, Ala and Gly and the
NAD(P)H:decylubiquinone oxidoreductase activities of the isolated
variants were measured. All variants showed an increased catalytic
efﬁciency with NADPH and NADH. All variants showed lower ROS
production with NADPH compared to the wildtype. The NADH
oxidation is accompanied with an enhanced ROS production most
likely due to the mode of nucleotide binding [3]. To correlate the
increased ROS production with nucleotide binding, the A. aeolicus
variants with bound substrates were crystallized.
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Fenpyroximate, a strong inhibitor of bovine NADH-ubiquinone
oxidoreductase (complex I), had been reported to bind to the ND5
subunit [1]. Considering that the main body of the ND5 subunit is
located at the distal end of the membrane domain as a part of proton-
pumping module [2], however, the previous result may be question-
able. Because establishing the number and location of inhibitors and/
or quinone binding sites in the membrane domain is necessary to
elucidate the function of the enzyme, it is critical to clarify whether
there are additional inhibitors and/or quinone binding site besides
the interface between the hydrophilic and membrane domains. We
therefore performed the photoafﬁnity labeling experiments using
two newly synthesized fenpyroximate derivatives [125I]APF and
[125I]AIF, possessing a photoreactive azido group at and far from the
pharmacophoric core moiety, respectively. Extensive biochemical and
proteomic analysis of the labeled bovine complex I revealed that the
residues labeled by [125I]APF and [125I]AIF are located in the region
Ser43-Arg66 (PSST) and Asp160-Arg174 (49 kDa), respectively [3],
which face the supposed quinone-binding pocket formed at the
interface of the PSST, 49 kDa, and ND1 subunits. These results
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